Home » Posts tagged with » California
Sorrento Therapeutics says STI-1499 fully inhibited SARS-CoV-2 virus

Sorrento Therapeutics says STI-1499 fully inhibited SARS-CoV-2 virus

Sorrento Therapeutics said that STI-1499, its anti-SARS-CoV-2 antibody, showed 100% inhibition of SARS-CoV-2 virus infection in an in vitro virus infection experiment at a very low antibody concentration. The US biotech company will look to create an antibody cocktail product that will work as a protective shield against SARS-CoV-2 coronavirus infection and stay effective even […]

Eiger BioPharmaceuticals doses first patients with Lambda in COVID-19 trial

Eiger BioPharmaceuticals said that it has dosed the first patients in a phase 2 trial of its hepatitis delta virus drug candidate peginterferon lambda (Lambda) in outpatients at the Stanford University School of Medicine having mild COVID-19. The California-based biopharma company said that nearly 120 patients will be randomly grouped in a 1:1 ratio to […]

Continue reading …
Verndari begins preclinical testing of COVID-19 vaccine candidate

Verndari, a California-based biopharma company, has started preclinical testing of a COVID-19 vaccine candidate, which will be administered using it microneedle array dermal patch VaxiPatch. The preclinical testing will be carried out in laboratories at the University of California in Davis (UC Davis). Verndari, which was established in 2015, is said to have developed the […]

Continue reading …
Gilead Sciences wraps up $4.9bn acquisition of Forty Seven

Gilead Sciences has completed its previously announced $4.9 billion acquisition of Forty Seven, a clinical-stage immuno-oncology company based in California. The immuno-oncology company has been acquired by the US biotech company for $95.50 per share in cash to become the latter’s fully-owned subsidiary. Forty Seven will be delisted from the Nasdaq Global Select Market. The […]

Continue reading …
ResMed launches tube-up full face CPAP mask AirFit F30i

ResMed, a California-based medical equipment company, has launched AirFit F30i, a tube-up full face continuous positive airway pressure (CPAP) mask for patients with obstructive sleep apnea. With the launch, the company has completed its full face mask portfolio on the market. Full face CPAP users have options to choose from the type of connection either […]

Continue reading …
Reneo Pharmaceuticals launches REN001 clinical trial in McArdle disease

Reneo Pharmaceuticals has initiated a phase 1b clinical trial of REN001 in glycogen storage disease type V (GSD V), also called McArdle disease. The California-based clinical-stage pharma company is currently enrolling participants into the early-stage clinical trial in the UK and Spain. Considered as an inherited disorder, McArdle disease is caused by the body’s inability […]

Continue reading …
ALX Oncology raises $105m to advance clinical development of ALX148

ALX Oncology, a clinical-stage immuno-oncology company based in California, has raised $105 million in a Series C equity financing round led by Vivo Capital. The US biotech company is focused on developing therapies to block the CD47 checkpoint mechanism. ALX Oncology will use the Series C proceeds to help expand the clinical development of its […]

Continue reading …
Pinpoint Therapeutics secures funds for developing autophagy inhibitors for cancer

Pinpoint Therapeutics, a US biopharma company focused on developing autophagy inhibitors for cancer treatment, has secured $1 million in debt financing led by California-based venture capital firm Kairos Ventures. The preclinical stage company was founded in 2018 through PCI Ventures, a division of the Penn Center for Innovation (PCI) at the University of Pennsylvania. It […]

Continue reading …
Nestlé increases stake in Aimmune Therapeutics after Palforzia FDA approval

Aimmune Therapeutics, which has recently bagged approval from the US Food and Drug Administration (FDA) for its peanut allergy drug PALFORZIA (formerly AR101), has secured an additional equity investment of $200 million from Nestlé Health Science. Based in California, Aimmune Therapeutics has been focused on the development and commercialization of treatments for potentially life-threatening food […]

Continue reading …
Wuhan Coronavirus can be detected by Explify Respiratory test says IDbyDNA

IDbyDNA claims that its Explify Respiratory test can detect Wuhan Coronavirus apart from more than 900 viral, bacterial, fungal, and parasitic pathogens. According to the California-based metagenomics technology company, the Explify Respiratory test is a validated laboratory-developed test for respiratory pathogens like human coronaviruses. The Wuhan Coronavirus detection test is currently available at the IDbyDNA […]

Continue reading …
Page 1 of 512345